Page last updated: 2024-08-25

rosiglitazone and Viremia

rosiglitazone has been researched along with Viremia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dou, H; Heilman, D; Knipe, B; Leibhart, J; Mercer, A; Morsey, B; Papugani, A; Persidsky, Y; Potula, R; Ramirez, SH; Schall, K	1

Other Studies

1 other study(ies) available for rosiglitazone and Viremia

Article	Year
Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis. AIDS (London, England), 2008, Aug-20, Volume: 22, Issue:13 Topics: AIDS Dementia Complex; Animals; Brain; Cells, Cultured; HIV Long Terminal Repeat; HIV-1; Humans; Macrophages; Mice; Mice, SCID; Models, Animal; NF-kappa B; PPAR gamma; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Viremia; Virus Replication	2008

Article

Year

Peroxisome proliferator-activated receptor-gamma activation suppresses HIV-1 replication in an animal model of encephalitis.

AIDS (London, England), 2008, Aug-20, Volume: 22, Issue:13

Topics: AIDS Dementia Complex; Animals; Brain; Cells, Cultured; HIV Long Terminal Repeat; HIV-1; Humans; Macrophages; Mice; Mice, SCID; Models, Animal; NF-kappa B; PPAR gamma; RNA Interference; RNA, Small Interfering; Rosiglitazone; Thiazolidinediones; Viremia; Virus Replication

2008